|
Positive Predictive Value (PPV) and Negative Predictive Value (NPV) for the diagnosis of HCC with αFP values ≥200, αFP values ≥ 400 ng/mL and with the progressive elevation of αFP of 5 ng/mL with a prevalence of 5 and 10%. |
|||
| αFP |
HCC Prevalence (%) |
PPV (%) |
NPV (%) |
|
|
|||
| ≥200 ng/ml |
10 |
97.58 |
93.4 |
| 5 |
95.03 |
96.7 |
|
| ≥400 ng/ml |
10 |
95.7 |
91.86 |
| 5 |
91.4 |
95.97 |
|
| Elevation ≥7 ng/ml/month |
10 |
98.7 |
96.92 |
| 5 |
97.4 |
98.52 |
|
Arrieta et al. BMC Cancer 2007 7:28 doi:10.1186/1471-2407-7-28 |
|||